Key result
Exogenous sulfatide dose-dependently inhibited in vitro platelet aggregation induced by collagen, thrombin, and ristocetin, as well as collagen-mediated serotonin release.
Why the study?
Does exogenous sulfatide inhibit human platelet function in vitro?
Does exogenous sulfatide inhibit human platelet function in vitro?
Sulfatides may play a physiological role in modulating platelet activation by inhibiting specific pathways of aggregation and release.
No takes yet. Share an insight, caveat, or question.
May suggest sulfatides modulate platelet activation; leaves open human in vivo effects and clinical relevance.
Devaiah et al. (2000) studied this question. Exogenous sulfatide was evaluated on Platelet adhesion, aggregation, release, and ristocetin-induced platelet agglutination. Exogenous sulfatide dose-dependently inhibited in vitro platelet aggregation induced by collagen, thrombin, and ristocetin, as well as collagen-mediated serotonin release.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: